| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
1) AI is primarily used in medical imaging to enhance diagnostic accuracy. It assists radiologists by analyzing medical images more quickly and often with greater precision than humans alone, detecting abnormalities such as tumors, fractures, and other conditions.
2) The goal is not just to reduce costs or automate administrative tasks but to provide better healthcare outcomes by aiding in the early detection of diseases.
3) The primary focus is on improving patient outcomes through more accurate diagnoses, rather than reducing the cost of equipment or automating administrative functions, which are secondary benefits. |
Medical AI Adoption Theory
This theory emphasizes that the primary goal of AI in healthcare is not to replace healthcare workers but to assist in making more accurate decisions, improving efficiency, and ultimately enhancing patient care. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
1) AI is used as a decision-support tool, offering a second opinion to radiologists. This helps reduce the likelihood of misdiagnosis, as AI can point out potential issues that might be overlooked or misinterpreted by a human radiologist.
2) It does not replace the radiologist but supports their decision-making by providing an additional layer of analysis.
3) The statement “Increases The Need For Radiologists” is incorrect because AI is intended to assist, not replace or increase the need for radiologists. |
Human-AI Collaboration in Medicine
This framework supports the idea that AI in healthcare works best when collaborating with humans rather than replacing them. AI in radiology serves to assist radiologists in providing better diagnoses, making the process more efficient.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
1) AI literacy in healthcare refers to healthcare professionals’ understanding of how AI systems work, their applications in medical settings, and the ethical considerations surrounding their use.
2) It does not refer to the ability to repair AI machines or manage financial aspects of AI systems, as these are technical roles that fall outside the scope of medical practice. |
Technology Acceptance Model (TAM)
According to this model, the understanding and knowledge of new technology, including AI, play a critical role in whether the technology is accepted and used effectively. Knowledge of AI’s capabilities and limitations promotes confidence in its use.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
1) Factors like trust, system integration, and understanding are critical to the acceptability of AI in healthcare. These factors directly influence how likely healthcare professionals are to adopt and trust AI systems.
2) The color of the AI machines is irrelevant to its effectiveness or acceptance. Aesthetic factors such as color or design do not influence how well healthcare professionals adopt AI technology in their practice. |
Technology Acceptance Model (TAM)
This model posits that factors such as ease of use, perceived usefulness, and trust are key determinants of whether a technology will be accepted. Aesthetic features, like the color of machines, are not significant in the decision-making process. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
1) Social influence plays a significant role in whether healthcare professionals adopt AI. Peer recommendations, institutional policies, and expert endorsements can heavily influence an individual’s decision to use or trust AI systems.
2) Social influence does not directly affect financial budgets or diagnostic accuracy. It shapes the decisions of healthcare professionals by guiding their perceptions and attitudes toward AI. |
Social Influence Theory
This theory suggests that decision-making is often influenced by the opinions and behaviors of others in one’s social network. In healthcare, social influence can come from peers, mentors, and the medical community, impacting whether AI systems are accepted and trusted.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
1) One of the most significant concerns regarding AI in healthcare is the fear that AI systems will replace healthcare professionals, particularly in roles like radiologists, surgeons, or general practitioners.
2) While AI is designed to assist, not replace, human professionals, there is a widespread perception that automation might lead to job losses or devaluation of human expertise in medical settings.
3) This concern is rooted in a fear of technological unemployment, a common theme in discussions about AI in various industries. |
Technological Unemployment Theory
This theory suggests that the advent of advanced technologies, such as AI, may lead to the displacement of human workers. While AI in healthcare is intended to assist, fears about its potential to replace human jobs reflect broader concerns about job security and automation.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
1) For AI systems to be widely accepted in medical settings, they must be human-centred, meaning they should be designed with consideration for how healthcare professionals interact with them. This includes making AI systems intuitive, easy to use, and aligned with healthcare workers’ workflows.
2) Ensuring that AI systems meet the needs and preferences of medical professionals, and designing systems that enhance rather than hinder their work, is crucial for acceptance.
3) The other options, like decreasing costs or ensuring high algorithmic performance, are important but secondary. Designing systems that are user-friendly and integrate well with existing practices is key. |
Human-Centered Design (HCD) Theory
This framework emphasizes designing technologies that prioritize the needs, preferences, and limitations of users (in this case, healthcare professionals). AI systems that are easy to use and align with healthcare workflows are more likely to be accepted and integrated.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
1) The ‘system usage’ category of AI acceptability refers to how well the AI system fits into the healthcare professional’s existing workflows. Factors like the value proposition (how beneficial the AI is to their work) and how seamlessly it integrates into daily tasks are key to determining whether a healthcare worker will accept and use the system.
2) Personal preferences may influence system usage to some extent, but the primary drivers of acceptability are the practical benefits and workflow compatibility of the AI system. |
Technology Acceptance Model (TAM)
According to this model, the acceptance of technology is heavily influenced by its perceived usefulness and ease of use. AI systems that provide clear value and integrate smoothly into existing systems are more likely to be accepted by healthcare professionals.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
1) Ethical considerations play a crucial role in determining how healthcare professionals view AI. They are more likely to accept AI systems that align with their professional values, such as patient confidentiality, informed consent, and the integrity of care.
2) Ethical concerns about AI often revolve around how decisions are made, the transparency of algorithms, and the potential for biases in AI models.
3) If AI systems are seen as conflicting with professional ethics, such as prioritizing efficiency over patient care or making decisions that lack transparency, their acceptance is likely to be lower. |
Ethical Decision-Making in Technology Adoption
This framework suggests that the ethical alignment of technology with the values of the user is crucial for its acceptance. In healthcare, ethics are fundamental, and AI systems that align with medical professionals’ ethical standards are more likely to be embraced. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
1) The article emphasizes the importance of deeply considering user experience and how well AI systems integrate with healthcare workflows in future AI acceptability studies. This focus is crucial because the success of AI adoption depends not only on the technology itself but on how it is used and integrated into real-world healthcare settings.
2) The focus is on understanding how healthcare professionals interact with AI, how it influences their work, and whether it genuinely enhances their effectiveness.
3) The options related to economic factors or prioritizing speed over accuracy are less relevant in the context of AI acceptance. User experience and system integration are the key factors to study. |
User-Centered Design (UCD) Framework
This approach focuses on understanding the user’s needs, preferences, and workflows when designing and implementing new technology. By deeply considering these aspects, AI systems are more likely to be accepted by healthcare professionals. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
1) Parkinson’s disease (PD) is characterized by the degeneration of dopamine-producing neurons in the brain, leading to motor symptoms like tremors and rigidity.
2) The goal of using human embryonic stem cells (hESCs) in PD treatment is to replace these lost dopamine neurons, restoring the dopamine levels in the brain and improving the motor function of patients.
3) While stem cells may have other potential benefits, such as promoting brain plasticity or neurogenesis, the primary aim in Parkinson’s disease treatment is the replacement of lost dopamine neurons. |
Neurorestoration Theory
This theory posits that stem cells, particularly dopamine-producing neurons derived from human embryonic stem cells, can replace the lost neurons in the brain to restore function and mitigate symptoms of neurodegenerative diseases like Parkinson’s. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
1) Rats are commonly used in preclinical studies due to their relatively low cost, well-understood biology, and similarity to humans in many aspects of neurophysiology.
2) In the context of Parkinson’s disease research, rats are often used as models because they allow researchers to test treatments in a controlled environment before human trials. They can replicate key aspects of Parkinson’s disease, such as dopamine deficiency, making them ideal for safety and efficacy testing. |
Animal Model Theory in Preclinical Research
1) Animal models are essential in preclinical research for understanding the potential effects of new treatments. Rats are commonly used in these studies because they share many physiological similarities with humans, and their use is well-established in scientific research.
2) In the context of Parkinson’s disease and stem cell therapy, animal models like rats are used to replicate aspects of the disease, such as dopamine deficiency, to observe how potential therapies, such as STEM-PD, might restore function or prevent neurodegeneration.
3) Preclinical research often relies on these animal models for testing safety and efficacy before human trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
6 months |
|
1) Preclinical studies, particularly those related to stem cell therapies or treatments for Parkinson’s disease, typically last between 3 to 12 months. The goal is to assess both short-term safety (such as immune responses or adverse effects) and long-term effects (such as the potential for tumor formation or tissue integration).
2) In most stem cell studies, 6 months is a reasonable time frame, allowing for both acute and chronic effects to be monitored. |
Preclinical Testing Duration in Stem Cell Research
The duration of preclinical testing is based on the therapeutic’s complexity and the need to observe both immediate and long-term effects. For stem cell products, a 6-month period is often chosen to provide sufficient data for safety evaluation before progressing to clinical trials.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
1) Phase 1/2a trials combine Phase 1 (focused on safety and dosage in a small group of patients) and Phase 2a (focused on early efficacy and dose optimization). This approach is often used for cutting-edge therapies like stem cell treatments.
2) The Phase 1 component evaluates safety, while the Phase 2a portion explores initial efficacy and determines the optimal dose.
3) This combined approach allows researchers to gain both safety and efficacy data early, which is crucial for innovative treatments that could move quickly into larger-scale trials (such as Phase 2 or Phase 3). |
Adaptive Trial Design
This framework allows flexibility in trial design, such as combining Phase 1 and Phase 2a, enabling quicker assessment of a new therapy’s safety and efficacy.
It is common for stem cell-based therapies to go through this kind of combined early-phase trial to streamline the process and address both safety and preliminary efficacy in a smaller cohort. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
1) Good Manufacturing Practices (GMP) are standards required for the production of pharmaceuticals and biologics, ensuring that products are consistently produced and controlled according to quality standards.
2) STEM-PD is likely manufactured under GMP-compliant conditions to ensure the product is safe, pure, and effective for clinical use. Manufacturing stem cell-based therapies involves complex procedures where stringent quality control is crucial for ensuring the safety of the product, especially for use in human clinical trials. |
Regulatory Compliance Framework
This framework emphasizes the importance of adhering to GMP and other regulatory standards when producing therapies, especially when dealing with stem cell-based products for human use. It ensures the safety, reproducibility, and quality of medical treatments. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
1) In preclinical studies of stem cell-based therapies, safety is evaluated by monitoring for adverse effects such as tumor formation or immune reactions. The absence of these effects typically confirms the safety of the product.
2) The confirmation of no adverse effects and the lack of tumor formation demonstrates that the product does not introduce significant risks to the rats in the study. |
Toxicology and Safety Assessment in Preclinical Trials
This framework highlights the importance of identifying adverse events, such as tumor formation or immune rejection, to evaluate the safety of new therapies, especially in early-stage studies.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
1) The key finding in the efficacy study was that the transplanted stem cells were able to reverse motor deficits in rats, which is the primary goal of using stem cells in Parkinson’s disease therapy. The cells likely differentiated into dopamine-producing neurons, addressing the dopamine deficiency in the brain that causes motor issues.
2) This positive outcome is essential for demonstrating the potential therapeutic benefit of the STEM-PD product. |
Cell Therapy for Neurological Disorders
This framework focuses on the use of stem cells to regenerate dopamine-producing neurons, which is crucial for the treatment of diseases like Parkinson’s that involve motor dysfunction.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
1) The purity of stem cell batches is essential for ensuring that the product contains only the desired cell types. GIRK2 and ALDH1A1 are dopaminergic markers commonly used to confirm the presence of dopamine-producing neurons.
2) The use of these markers indicates that the stem cells are correctly differentiated into the desired neural cell types needed for the treatment of Parkinson’s disease. |
Cell Purity and Differentiation Markers:
In stem cell research, markers like GIRK2 and ALDH1A1 are essential for identifying dopaminergic neurons, ensuring that the therapeutic product is effective and free from undifferentiated or unwanted cell types.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
1) FGF8b and SHH (Sonic Hedgehog) are growth factors involved in the patterning and differentiation of neural progenitors. These growth factors help guide stem cells to differentiate into specific types of neurons, such as dopaminergic neurons that are needed for Parkinson’s disease treatment.
2) The presence of these growth factors ensures that the cells differentiate into the correct neural lineage. |
Neurogenesis and Stem Cell Differentiation
This framework focuses on the role of growth factors in guiding stem cells toward specific neural fates in the process of neuronal differentiation.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
1) The key outcome in preclinical trials for Parkinson’s disease treatments is typically the restoration of motor function, which is impaired in patients due to the loss of dopamine neurons.
2) In this case, the preclinical efficacy study showed that the transplanted cells successfully reversed the motor deficits, which indicates the product’s potential to improve motor function in patients with Parkinson’s disease. |
Motor Function Restoration in Neurodegenerative Diseases
This framework focuses on the restoration of motor function as a primary goal of therapies for Parkinson’s disease, using stem cell-based interventions to replace lost neurons and improve motor skills.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|